Science Explorer Back to mapMap
Discussion
Researcher · CHA University · South Korea

Nam-Chul Jung

Nam-Chul Jung publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immunotherapy and Immune Responses, T-cell and B-cell Immunology and CAR-T cell therapy research.

ORCID 0000-0002-9250-3304 OpenAlex
World rank
#2,433,127
of 7,710,434 ranked researchers
Rank in South Korea
#32,866
of 162,609
Works
29
Citations
800
Citations per work
27.6
h-index
13
i10-index 15Top 57% in Immunology
Nam-Chul Jung

What does Nam-Chul Jung research?

Nam-Chul Jung's work is mostly in Immunology and Microbiology (33%), Medicine (17%), Biochemistry, Genetics and Molecular Biology (7%).

Life Sciences: 12 works · 40.4% of their workImmunology and Microbiology: 10 works · 33.3% of their workImmunology: 10 works · 33.3% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 7.1% of their workMolecular Biology: 2 works · 7.1% of their workEverything else: 11 works · 39.3% of their workHealth Sciences: 5 works · 16.7% of their workMedicine: 5 works · 16.7% of their workOncology: 3 works · 9.5% of their workEpidemiology: 1 works · 3.6% of their workSurgery: 1 works · 3.6% of their workPhysical Sciences: 1 works · 3.6% of their workEngineering: 1 works · 3.6% of their workElectrical and Electronic Engineering: 1 works · 3.6% of their workTHEIR WORKNam-Chul Jung29works
Life Sciences40%Physical Sciences4%Health Sciences17%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology1033.3%
    2. Biochemistry, Genetics and Molecular Biology27.1%
  2. Everything else1139.3%
    1. Medicine516.7%
    1. Engineering13.6%
  1. 1Immunology33% of their works
  2. 2Oncology10% of their works
  3. 3Molecular Biology7% of their works
  4. 4Surgery4% of their works
  5. 5Electrical and Electronic Engineering4% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Nam-Chul Jung's research?

The keywords of their largest research topics: Cancer Immunotherapy, Dendritic Cells, Immunity, Antigen Presentation, Tumor Antigen, CAR T Cells, Chimeric Antigen Receptor and Foxp3.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Cancer Immunotherapy212 topics
  2. Dendritic Cells172 topics
  3. Immunity172 topics
  4. Antigen Presentation151 topic
  5. Tumor Antigen151 topic
  6. CAR T Cells61 topic
  7. Chimeric Antigen Receptor61 topic
  8. Foxp361 topic
  9. Inflammation63 topics
  10. TGF-ß61 topic
  11. NK Cell Recognition41 topic
  12. Natural Killer Cells41 topic
  13. Atherosclerosis21 topic
  14. Immune Response21 topic
  15. NF-?B21 topic
  16. NR4A221 topic
  17. Nurr121 topic
  18. RNA Interference21 topic
  19. Signaling21 topic
  20. siRNA Delivery21 topic

Where does Nam-Chul Jung work?

Nam-Chul Jung's main affiliation in the publication record is CHA University, South Korea.

How many publications and citations does Nam-Chul Jung have?

OpenAlex counts 29 works and 800 citations for Nam-Chul Jung, an h-index of 13, ranking #2,433,127 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Nam-Chul Jung

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nam-Chul Jung. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.